Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $2.951B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 19,751,284 | $1.07B | 36.2% | — | — | CLASS A ORD | 61559X104 |
| KYMR | KYMERA THERAPEUTICS INC | 5,161,801 | $208M | 7.0% | — | — | COM | 501575104 |
| RVMD | REVOLUTION MEDICINES INC | 4,181,179 | $183M | 6.2% | — | — | COM | 76155X100 |
| AXSM | AXSOME THERAPEUTICS INC | 1,388,064 | $117M | 4.0% | — | — | COM | 05464T104 |
| MIRM | MIRUM PHARMACEUTICALS INC | 2,796,513 | $116M | 3.9% | — | — | COM | 604749101 |
| XOMA | XOMA ROYALTY CORPORATION | 3,633,743 | $95.49M | 3.2% | — | — | COM NEW | 98419J206 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1,900,015 | $73.34M | 2.5% | — | — | COM | 74366E102 |
| GHRS | GH RESEARCH PLC | 10,400,158 | $72.8M | 2.5% | — | — | ORDINARY SHARES | G3855L106 |
| CGEM | CULLINAN THERAPEUTICS INC | 5,750,683 | $70.04M | 2.4% | — | — | COM | 230031106 |
| ZYME | ZYMEWORKS INC | 4,308,935 | $63.08M | 2.1% | — | — | COM | 98985Y108 |
| SEPN | SEPTERNA INC | 2,452,024 | $56.15M | 1.9% | — | — | COM | 81734D104 |
| TYRA | TYRA BIOSCIENCES INC | 3,944,194 | $54.82M | 1.9% | — | — | COM | 90240B106 |
| ACIU | AC IMMUNE SA | 19,522,436 | $52.71M | 1.8% | — | — | SHS | H00263105 |
| XNCR | XENCOR INC | 2,288,760 | $52.6M | 1.8% | — | — | COM | 98401F105 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,771,417 | $48.04M | 1.6% | — | — | SPONSORED ADS | 86366E106 |
| CELC | CELCUITY INC | 3,466,000 | $45.37M | 1.5% | — | — | COM | 15102K100 |
| GLPG | GALAPAGOS NV | 1,569,422 | $43.16M | 1.5% | — | — | SPON ADR | 36315X101 |
| — | VERVE THERAPEUTICS INC | 6,904,050 | $38.94M | 1.3% | — | — | COM | 92539P101 |
| ANNX | ANNEXON INC | 7,000,000 | $35.91M | 1.2% | — | — | COM | 03589W102 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1,073,755 | $35.28M | 1.2% | — | — | COM | 00847X104 |
| — | 89BIO INC | 4,333,885 | $33.89M | 1.1% | — | — | COM | 282559103 |
| OLMA | OLEMA PHARMACEUTICALS INC | 5,715,893 | $33.32M | 1.1% | — | — | COM | 68062P106 |
| — | CIDARA THERAPEUTICS INC | 1,092,796 | $29.37M | 1.0% | — | — | COM NEW | 171757206 |
| ELDN | ELEDON PHARMACEUTICALS INC | 6,293,282 | $25.93M | 0.9% | — | — | COM | 28617K101 |
| FHTX | FOGHORN THERAPEUTICS INC | 5,302,000 | $25.03M | 0.8% | — | — | COM | 344174107 |
| — | THIRD HARMONIC BIO INC | 2,372,933 | $24.42M | 0.8% | — | — | COM | 88427A107 |
| KURA | KURA ONCOLOGY INC | 2,567,469 | $22.36M | 0.8% | — | — | COM | 50127T109 |
| — | ALLAKOS INC | 16,552,417 | $20.03M | 0.7% | — | — | COM | 01671P100 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 2,764,471 | $19.19M | 0.7% | — | — | COM | 61225M102 |
| — | ITEOS THERAPEUTICS INC | 2,325,000 | $17.86M | 0.6% | — | — | COM | 46565G104 |
| — | ESSA PHARMA INC | 8,748,629 | $15.66M | 0.5% | — | — | COM NEW | 29668H708 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 2,670,642 | $14.88M | 0.5% | — | — | COM | 35104E100 |
| — | RAPT THERAPEUTICS INC | 9,237,556 | $14.6M | 0.5% | — | — | COM | 75382E109 |
| ENGN | ENGENE HOLDINGS INC | 2,106,037 | $14.01M | 0.5% | — | — | COM | 29286M105 |
| — | REPARE THERAPEUTICS INC | 10,333,600 | $13.54M | 0.5% | — | — | COM | 760273102 |
| FBRX | FORTE BIOSCIENCES INC | 594,282 | $13.5M | 0.5% | — | — | COM NEW | 34962G208 |
| VSTM | VERASTEM INC | 2,100,468 | $10.86M | 0.4% | — | — | COM NEW | 92337C203 |
| TCRX | TSCAN THERAPEUTICS INC | 2,989,474 | $9.088M | 0.3% | — | — | COM | 89854M101 |
| IMUX | IMMUNIC INC | 8,902,972 | $8.903M | 0.3% | — | — | COM | 4525EP101 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 696,555 | $8.359M | 0.3% | — | — | COM | 697947109 |
| AVTX | AVALO THERAPEUTICS INC | 1,036,679 | $7.703M | 0.3% | — | — | COM NEW | 05338F306 |
| — | IKENA ONCOLOGY INC | 4,006,564 | $6.571M | 0.2% | — | — | COM | 45175G108 |
| MOLN | MOLECULAR PARTNERS AG | 1,353,968 | $6.458M | 0.2% | — | — | ADS | 60853G106 |
| CTMX | CYTOMX THERAPEUTICS INC | 5,228,461 | $5.385M | 0.2% | — | — | COM | 23284F105 |
| OVID | OVID THERAPEUTICS INC | 3,853,818 | $3.598M | 0.1% | — | — | COM | 690469101 |
| SABS | SAB BIOTHERAPEUTICS INC | 917,826 | $3.506M | 0.1% | — | — | COM NEW | 78397T202 |
| — | VIGIL NEUROSCIENCE INC | 1,813,633 | $3.083M | 0.1% | — | — | COM | 92673K108 |
| — | GLYCOMIMETICS INC | 9,544,262 | $2.377M | 0.1% | — | — | COM | 38000Q102 |
| TENX | TENAX THERAPEUTICS INC | 339,549 | $2.102M | 0.1% | — | — | COM NEW | 88032L605 |
| — | ELEVATION ONCOLOGY INC | 2,966,836 | $1.669M | 0.1% | — | — | COM | 28623U101 |
| IVA | INVENTIVA SA | 686,040 | $1.475M | 0.0% | — | — | ADS | 46124U107 |
| ENGNW | ENGENE HOLDINGS INC | 945,402 | $804K | 0.0% | — | — | *W EXP 10/31/202 | 29286M113 |
| — | NLS PHARMACEUTICS LTD | 143,676 | $303K | 0.0% | — | — | COM NEW | H57830137 |